The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cells

The USFDA approved “epigenetic drug”, Decitabine, exerts its effect by hypomethylating DNA, demonstrating the pivotal role aberrant genome-wide DNA methylation patterns play in cancer ontology. Using sensitive technologies in a cellular model of Acute Myeloid Leukemia, we demonstrate that while Deci...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Sci Rep
Hoofdauteurs: Chowdhury, Basudev, McGovern, Andrew, Cui, Yi, Choudhury, Samrat Roy, Cho, Il-Hoon, Cooper, Bruce, Chevassut, Timothy, Lossie, Amy C., Irudayaraj, Joseph
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4894448/
https://ncbi.nlm.nih.gov/pubmed/25901663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep09281
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items